Beijing Friendship Hospital Affiliated to Capital Medical University
Beijing, Beijing Municipality, 100000, China
Location status: Recruiting
NCT Number: NCT07611266
This project focuses on developing a risk prediction model for the recurrence and malignant transformation of colorectal adenomas by integrating multimodal features from both Traditional Chinese Medicine (TCM) and Western medicine. Led by Dr. Wei Hongtao from Beijing Friendship Hospital, Capital Medical University, the primary objective is to mine clinical characteristics from both medical systems to construct a robust predictive model. The research encompasses several key aspects: a multicenter, large-sample cohort study design with a clearly defined sample size and calculation basis; patient recruitment from multiple institutions nationwide to form training and validation sets; and strict adherence to standardized TCM and Western diagnostic criteria. Through comprehensive observation of demographic, TCM clinical (e.g., syndromes, tongue and pulse diagnosis), and Western clinical features, the study ensures data accuracy via rigorous monitoring and follow-up. Various algorithms are employed to extract and analyze these multi-source features-including endoscopic data-to build and evaluate the prediction model. Furthermore, the study aims to identify dominant subgroups to optimize TCM intervention strategies. Key performance indicators include establishing the risk model, identifying target populations, publishing high-quality papers, and training graduate students. By innovatively constructing this multimodal fusion model, the project provides a novel perspective and evidence-based foundation for the prevention and treatment of colorectal adenomas using TCM.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Beijing, Beijing Municipality, 100000, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From enrollment to study completion, up to 3 years (average 1.5 years)
Time frame: From enrollment to study completion, up to 3 years (average 1.5 years)
Time frame: From enrollment to study completion, up to 3 years (average 1.5 years)
Contact information is provided by the study sponsor or research team.
Beijing Friendship Hospital
Other
Study on the Prediction Model of Recurrence and Carcinogenesis Risk of Colorectal Adenoma Based on the Fusion of Traditional Chinese and Western Medicine Multimodal Features
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06974500
Colorectal Cancer Control and Prevention, Postoperative Ileus
Madrid, Spain
View Trial DetailsNCT06775951
Colorectal Cancer Control and Prevention
Bologna, Italy
View Trial DetailsNCT06629051
Colonic Diseases, Colorectal Adenoma
Shanghai, China
View Trial DetailsNCT06625983
Colorectal Cancer Control and Prevention, Colorectal Cancer Screening
Boston, Massachusetts, United States
View Trial Details